Table 2. Evaluation of the surgical outcomes of thoracic duct terminal adhesion release for the treatment of primary chylopericardium with different non-enhancing MRL type.
| Variable | Type I or II (n=22) | Type III (n=17) |
Type IV (n=17) |
P value | |||
|---|---|---|---|---|---|---|---|
| All | Type I or II vs. III |
Type I or II vs. IV |
Type III vs. IV |
||||
| Volume of pericardial fluid pericardial fluid | |||||||
| Decreased | 17 (77.3) | 4 (23.5) | 6 (35.3) | 0.002 | 0.001 | 0.008 | 0.452 |
| No change | 4 (18.2) | 11 (64.7) | 9 (52.9) | 0.009 | 0.003 | 0.02 | 0.486 |
| Increased | 1 (4.5) | 2 (11.8) | 2 (11.8) | 0.72 | 0.57 | 0.57 | >0.99 |
| Duration of hospitalization (d) | 10 [3] | 10 [6] | 11 [10] | 0.7 | – | – | – |
Data are expressed as n (%) or median [IQR]. MRL, magnetic resonance lymphangiography; IQR, interquartile range.